The surge in poison control calls linked to Ozempic and Wegovy, two popular weight-loss drugs, has sparked concern among researchers and healthcare professionals. This trend, coinciding with the FDA's approval of semaglutide for chronic weight management in 2021, highlights the complex relationship between medication usage and public health. The article delves into the findings of a study conducted by Jordan Miller, a former undergraduate student, and her research team, which aimed to investigate the connection between the FDA's approval and the rise in poison control cases.
The study revealed a dramatic increase in GLP-1RA-related poison control calls, with semaglutide being the most prominent. Before 2021, these centers typically handled around 1,000-1,500 cases annually. However, after the FDA's approval, this number skyrocketed to over 8,000 by 2023. While most incidents were accidental dosing errors, the sheer magnitude of the increase was surprising. Jordan Miller noted the dominance of semaglutide, which was expected but still staggering.
The research team, including David Han and Long School of Medicine researchers, analyzed national poison control data and found a clear turning point after the FDA's approval. The number and type of calls shifted, reflecting the drug's expanded use for weight management. This shift in usage raises concerns about the drug's long-term safety, as its behavior in the body is not yet fully understood.
The study also identified preventable dosing mistakes as a significant contributor to poison control cases. Patients were often taking the medication daily instead of weekly and starting with the highest dose, which could have been avoided with better education. The researchers emphasize the need for improved patient education at every stage of the prescribing process to prevent medication errors.
The findings were published in reputable journals, including the Journal of Medical Toxicology, and received recognition at UT San Antonio's Los Datos conference. This research highlights the power of data science in uncovering public health trends and the importance of translating data into meaningful insights for informed action. It also underscores the need for ongoing research and education to ensure the safe and effective use of medications like Ozempic and Wegovy.
